Although DCIS has a better prognosis than invasive breast cancers, healing in this study correlated with poorer histologic features such as high‐grade, comedo necrosis, and predominantly HER2‐positive DCIS. The gene discussed is ERBB2; the disease is invasive breast carcinoma.